Read articles from Global

October 08, 2026 by youtube.com

What is inside a nicotine pouch matters because consumers deserve to understand the products they use. Beyond nicotine, pouches typically contain plant-based fibres, pH adjusters, flavourings, sweeteners and stabilisers that affect how the product feels, tastes and delivers nicotine. That does not make them risk-free, but it does make them very different from cigarettes, where burning tobacco creates thousands of toxic chemicals. Better public health communication should explain product contents clearly, rather than leaving nicotine pouches to be judged by suspicion alone.

October 07, 2026 by substack.com

She was first told to smoke, then judged for needing a way out. That contradiction captures a long public health failure: people were encouraged into cigarettes by culture, marketing and social norms, then later treated as the problem when they struggled to quit. Harm reduction starts from a more humane place. It recognises dependence, history and circumstance, and gives people safer routes away from combustion without turning their past into a moral verdict.

October 07, 2026 by medium.com

“Safer” is not a loophole in public health; it is the point of harm reduction. For people who cannot or will not stop using nicotine immediately, the difference between burning tobacco and using a lower-risk product can be the difference between continued exposure and meaningful risk reduction. Demanding “safe” before accepting “safer” leaves cigarettes with an advantage they do not deserve. Public health should care about every step that moves people away from the most harmful option.

September 30, 2026 by quitlikesweden.org

The evidence base for nicotine pouches is becoming harder to dismiss as a niche issue. As smoke-free, non-combustible products, pouches may offer adult smokers another route away from cigarettes, particularly where acceptability and everyday use matter. Their role should be assessed through toxicology, switching behaviour and population-level impact rather than moral discomfort with nicotine. A credible tobacco policy should ask whether these products reduce exposure to the harms of smoking — and regulate them accordingly.

September 29, 2026 by gfn.tv

Cardiovascular risk is one of the places where nicotine policy needs the most precision. New nicotine products should be assessed by what they do to exposure, biomarkers and real-world switching, not by assuming every product carries the same risk as smoking. Cigarettes remain uniquely harmful because combustion drives a major share of cardiovascular damage. The evidence debate should help smokers understand relative risk clearly, while still recognising uncertainty where the science is still developing.

September 29, 2026 by thehill.com

Vaping policy should not depend on which party finds it useful in a campaign cycle. Adult smokers need clear information, legal lower-risk options and safeguards that keep products away from young people. Turning vaping into a partisan symbol risks flattening the evidence into slogans, whether the aim is tougher restriction or faster authorisation. The real test is simpler: does the policy reduce smoking-related harm while keeping the market accountable?

September 28, 2026 by substack.com

Vape prohibitions promise control, but their real legacy is often a messier market. Legal products disappear from view, illicit sellers gain room to operate, and adult smokers lose one of the most accessible routes away from cigarettes. The policy may look firm, yet the behaviour it tries to stop simply moves elsewhere. Harm reduction starts from that reality: people need safer options that are legal, regulated and easier to choose than the dangerous ones.

September 28, 2026 by substack.com

Nicotine pouches are gaining ground because they solve practical problems that policy often overlooks. They are smoke-free, discreet, easy to use and do not require combustion, making them a workable alternative for adults who want nicotine without cigarettes. Their success should not be treated as a mystery or a threat by default. It should be understood as a signal that consumers respond to products that fit real life while reducing exposure to the harms of smoking.

September 23, 2026 by substack.com

Electronic medical records can look objective while still giving researchers a distorted view of behaviour. Smoking status, vaping history, dual use and switching are often recorded incompletely or reduced to crude categories that miss the timing and direction of change. For nicotine research, those gaps matter because the difference between “ever used” and “switched away from cigarettes” can alter the entire interpretation of risk. Better data means better science — and better science means better policy.

September 21, 2026 by snusforumet.se

The safer nicotine option should be the easier option. That principle is simple, but many policies still do the opposite by keeping cigarettes familiar, affordable or accessible while making lower-risk alternatives harder to find or understand. Adult smokers need a path away from combustion that is practical in the real world, not only acceptable in theory. Harm reduction works best when regulation makes the less harmful choice the obvious one.